Role of defibrillation threshold testing in the contemporary defibrillator patient population

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 4, 2013, Pages 437-441

  Vischer, Annina S ^a   Sticherling, Christian ^a   Kühne, Michael S ^a   Osswald, Stefan ^a   Schaer, Beat A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

amiodarone; cardiomyopathy; defibrillation threshold testing; heart failure; implantable cardioverter defibrillator

Indexed keywords

AMIODARONE; DOBUTAMINE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATION THRESHOLD; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION; T WAVE; UNIVARIATE ANALYSIS;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRIC COUNTERSHOCK; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT SAFETY; FEMALE; HEART FAILURE; HUMANS; MALE; MATERIALS TESTING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 84875842763     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12042     Document Type: Article

References (40)

1. Langer A, Heilman MS, Mower MM, Mirowski M,: Considerations in the development of the automatic implantable defibrillator. Med Instrum 1976; 10: 163-167.
2. Mirowski M, Mower MM, Langer A, Heilman MS, Schreibman J,: A chronically implanted system for automatic defibrillation in active conscious dogs. Experimental model for treatment of sudden death from ventricular fibrillation. Circulation 1978; 58: 90-94.
3. Mirowski M, Mower MM, Reid PR,: The automatic implantable defibrillator. Am Heart J 1980; 100 (6 Pt 2): 1089-1092.
4. Mirowski M, Reid PR, Watkins L, Weisfeldt ML, Mower MM,: Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillator. Am Heart J 1981; 102: 265-270.
5. Watkins L Jr, Mirowski M, Mower MM, Reid PR, Griffith LS, Vlay SC, Weisfeldt ML, Gott VL,: Automatic defibrillation in man. The initial surgical experience. J Thorac Cardiovasc Surg 1981; 82: 492-500.
6. Mirowski M, Mower MM, Reid PR, Watkins L Jr,: Implantable automatic defibrillators: Their potential in prevention of sudden coronary death. Ann NY Acad Sci 1982; 382: 371-380.
7. Copeland RB,: Implantable automatic cardioverter-defibrillator: Advanced technology which raises basic questions about the science of managerial decisions for clinical practice. Trans Am Clin Climatol Assoc 1984; 95: 176-182.
8. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
9. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
10. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH,: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
11. Zilo P, Weiss DN, Luceri RM,. Late retesting of system performance in ICD patients without spontaneous shocks. Pacing Clin Electrophysiol 1999; 22 (1 Pt 2): 197-201.
12. Ellenbogen K,: Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. 4th ed. Philadelphia PA: Elsevier/Saunders, 2011.
13. Winkle RA, Bach SM Jr, Mead RH, Gaudiani VA, Stinson EB, Fain ES, Schmidt P,: Comparison of defibrillation efficacy in humans using a new catheter and superior vena cava spring-left ventricular patch electrodes. J Am Coll Cardiol 1988; 11: 365-370.
14. Marchlinski FE, Flores B, Miller JM, Gottlieb CD, Hargrove WC III,: Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol 1988; 62: 393-398.
15. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes F-A, Krahn A, Parkash R, Khaykin Y, Philippon F, Guerra P, Kimber S, Cameron D, Healey JS,: Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm 2008; 5: 387-390.
16. Vlay SC,: Defibrillation threshold testing in the 21st century: Necessary or not Pacing Clin Electrophysiol 2009; 32: 565-566.
17. Kolb C, Zrenner B, Schmitt C,: Near-fatal incident on routine induction of ventricular fibrillation at the replacement of an implantable cardioverter defibrillator. Int J Cardiol 2006; 112: e74-e75.
18. Singer I, Edmonds H Jr,: Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing. Am Heart J 1994; 127 (4 Pt 2): 1052-1057.
19. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W,: Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005; 28: 926-932.
20. Stein KM, Devereux RB, Hahn RT, Markowitz SM, Mittal S, Iwai S, Lerman BB,: Effect of transthoracic shocks on left ventricular function. Resuscitation 2005; 66: 309-315.
21. Steinbeck G, Dorwarth U, Mattke S, Hoffmann E, Markewitz A, Kaulbach H, Tassani P,: Hemodynamic deterioration during ICD implant: Predictors of high-risk patients. Am. Heart J 1994; 127 (4 Pt 2): 1064-1067.
22. Joglar JA, Kessler DJ, Welch PJ, Keffer JH, Jessen ME, Hamdan MH, Page RL,: Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 1999; 83: 270-272, A6.
23. Michowitz Y, Lellouche N, Contractor T, Bourke T, Wiener I, Buch E, Boyle N, Bersohn M, Shivkumar K,: Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace 2011; 13: 683-688.
24. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ,: Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591-2596.
25. Lever NA, Newall EG, Larsen PD,: Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 2007; 9: 1054-1058.
26. Healey JS, Connolly S,. Shockless Implant Evaluation (SIMPLE) [Internet]. Available from: http://clinicaltrials.gov/ct2/show/NCT00800384?term= defibrillator+testing&rank=1 (Accessed June 20, 2012).
27. Bianchi S, Ricci RP, Biscione F, Sgreccia F, Di Belardino N, Rossi P, Giuli S, Grammatico A, De Santo T, Santi E, Merico M, Piccirillo G, Azzolini P, Santini M, Puglisi A,: Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Pacing Clin Electrophysiol 2009; 32: 573-578.
28. Swerdlow CD, Russo AM, Degroot PJ,: The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007; 30: 675-700.
29. Healey JS, Dorian P, Mitchell LB, Talajic M, Philippon F, Simpson C, Yee R, Morillo CA, Lamy A, Basta M, Birnie DH, Wang X, Nair GM, Crystal E, Kerr CR, Connolly SJ,: Canadian Registry of ICD Implant Testing procedures (CREDIT): Current practice, risks, and costs of intraoperative defibrillation testing. J Cardiovasc Electrophysiol 2010; 21: 177-182.
30. Healey JS, Birnie DH, Lee DS, Krahn AD, Crystal E, Simpson CS, Dorian P, Chen Z, Cameron D, Verma A, Connolly SJ, Gula LJ, Lockwood E, Nair G, Tu JV,: Defibrillation testing at the time of ICD insertion: An analysis from the Ontario ICD Registry. J Cardiovasc Electrophysiol 2010; 21: 1344-1348.
31. Sticherling C, Schaer B, Kühne M, Osswald S,: A plea for delivery of high-voltage shocks during implantable cardioverter-defibrillator replacement or system upgrade. Can J Cardiol 2012;28:611.e5-6.
32. McDaniel WC, Schuder JC,: The cardiac ventricular defibrillation threshold: Inherent limitations in its application and interpretation. Med Instrum 1987; 21: 170-176.
33. Calvi V, Dugo D, Capodanno D, Arancio R, Di Grazia A, Liotta C, Puzzangara E, Ragusa A, Arestia A, Tamburino C,: Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it Am Heart J 2010; 159: 98-102.
34. Reichlin T, Kühne M, Sticherling C, Osswald S, Schaer B,: Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation. QJM 2011; 104: 849-857.
35. Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, Bardy GH,. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008; 52: 551-556.
36. Verma A, Kaplan AJ, Sarak B, Oosthuizen R, Beardsall M, Higgenbottam J, Wulffhart Z, Khaykin Y,: Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation. J Interv Card Electrophysiol 2010; 29: 127-133.
37. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE,: Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion Heart Rhythm 2005; 2: 456-461.
38. Pires LA, Johnson KM,. Intraoperative testing of the implantable cardioverter-defibrillator: How much is enough J Cardiovasc Electrophysiol 2006; 17: 140-145.
39. Healey JS, Gula LJ, Birnie DH, Sterns L, Connolly SJ, Sapp J, Crystal E, Simpson C, Exner DV, Kus T, Philippon F, Wells G, Tang AS,: A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: A substudy of the RAFT Trial [Internet]. J Cardiovasc Electrophysiol 2012; Available from: http://www.ncbi.nlm.nih.gov/ pubmed/22788915
40. Guenther M, Rauwolf T, Brüggemann B, Gerlach M, Wässnig NK, Christoph M, Braun MU, Strasser RH, Wunderlich C,: Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: A measure of safety or out of date? A retrospective analysis of 975 patients. Europace 2012; 14: 217-223.